2005 discharge: European Medicines Agency

This procedure concerns the formal approval of the European Medicines Agency's (EMA) budget management for the 2005 financial year. The discharge process is a key part of democratic oversight, ensuring that the agency spent its allocated funds transparently and according to EU financial regulations.

This decision affects the EMA's administration and accountability. It confirms whether the agency's financial operations were handled correctly, providing a legal closure to that specific budget year.